Dabrafenib Mesylate and Jivi Intravenous
Determining the interaction of Dabrafenib Mesylate and Jivi Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
Generic Name: antihemophilic factor
Brand name: Jivi, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Obizur
Synonyms: Jivi
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabrafenib Mesylate-Jolessa
- Dabrafenib Mesylate-Jolessa extended-cycle
- Dabrafenib Mesylate-Jolivette
- Dabrafenib Mesylate-Jornay PM
- Dabrafenib Mesylate-Juleber
- Dabrafenib Mesylate-Juluca
- Jivi Intravenous-Dacarbazine
- Jivi Intravenous-Dacarbazine Intravenous, Injection
- Jivi Intravenous-Daclatasvir
- Jivi Intravenous-Daclatasvir Dihydrochloride
- Jivi Intravenous-Daclizumab
- Jivi Intravenous-Daclizumab Subcutaneous